Dr. Sarah Rossmiller Carroll, MD

Dr. Carroll practices at ENT Associates Medical Group in Oceanside, California.

Dr. Carroll's NPI, 1962608281, was assigned on June 23, 2007. Dr. Carroll graduated from Keck School of Medicine of USC in 2006. Dr. Carroll holds California license A117013.

Dr. Carroll's primary practice is ENT Associates Medical Group, at 3907 Waring Rd Suite 1 Suite 1, Oceanside, CA 92056-4405. The practice phone is (760) 724-8749.

Dr. Carroll's primary practice is ENT Associates Medical Group in Oceanside, California. Dr. Carroll is also affiliated with Sharp Tri-City Medical Center. The medical group on file is ENT Associates. Dmand AI also links Dr. Carroll to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carroll practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Carroll's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Carroll is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Carroll's licenses on file in 2 states: California and Oregon.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and swimmer's ear among the conditions Dr. Carroll treats.

CMS data shows 935 Medicare services from Dr. Carroll across 9 procedure codes in 2024, for 321 Medicare patients. Medicare paid $83,722 for them. Every service was in an office.

CMS counts 321 Medicare patients who saw Dr. Carroll in 2024. The largest group is 65 to 74, with 141 patients. 74% of them have high cholesterol, and 65% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Carroll's median patient age at 66, with 55% women.

In 2024, Dr. Carroll wrote 597 Medicare Part D claims for 253 patients. 97% of them were for generic drugs. CMS names the drug for 443 of them, across 13 drugs with 11 or more claims each, at $8,289 in total drug cost. In 2023, CMS named 411 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Carroll for performance year 2024, reported as part of a group. Dr. Carroll accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Carroll in 2012. Dr. Carroll's most frequent co-authors are Carol Jeanne MacArthur, MD, Henry Alexander Milczuk, MD and Zachary Michael Soler, MD.

CMS Open Payments shows 91 general payments to Dr. Carroll from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $745.

Dmand AI lists 1 award for Dr. Carroll, most recently CMS Stage 1 EHR in 2014.

Dr. Carroll graduated from Keck School of Medicine of USC in 2006.

Dr. Carroll is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.